Contact Us   |   Sign In   |   Join
Treatment, Vaccines and Diagnostics

MAY

Potential Covid Vaccine Speeds Growth at Catalent

 

SAB Biotherapeutics Confirms Neutralizing Antibodies to SARS-CoV-2 and Begins Clinical Manufacturing of Novel

COVID-19 Therapeutic Candidate

 

Merck and Ridgeback Bio Collaborate to Advance Development of Novel Antiviral Candidate, EIDD-2801

 

AVI and Merck Collaborate to Develop Vaccine Against SARS-CoV-2

 

Merck to Apply its Industry-Leading Vaccine Development Capabilities to SARS-CoV-2 Vaccine Program Originated by

Themis and Institut Pasteur

 

Merck to Announce Multiple Scientific Efforts to Combat COVID-19

 

Contract for Covid-19 testing component will bring expansion, 300 jobs to Lenexa

 

COVID-19 study looks at genetics of healthy people who develop severe illness

 

MU researcher identifies four possible treatments for COVID-19

 

Global study to test malaria drug to protect health workers from COVID-19


Takeda, CSL-led alliance and NIH to test COVID-19 plasma treatment this summer

 

MRIGlobal To Deliver Three Mobile Medical Labs For Department Of Defense

 

Pfizer producing new Covid-19 vaccine for clinical trials at St. Louis County facility

 

Pfizer and BioNTECH dose first participants in the U.S. as part of global COVID-19 mRNA vaccine development program

 

Insight into FDA’s Revised Policy on Antibody Tests: Prioritizing Access and Accuracy

 

US allows use of 1st drug shown to help virus recovery

 

April

 

We need more covid-19 tests. We propose a ‘shark tank’ to get us there.

 

FDA allows Novartis to test hydroxychloroquine against COVID-19

 

NIH partners with 16 drug companies in hopes of accelerating Covid-19 treatments and vaccines

 

The race for antibodies

 

Pfizer Advances Battle Against COVID-19 on Multiple Fronts

 

Sanofi and GSK to join forces in unprecedented vaccine collaboration to fight COVID-19

 

Amgen And Adaptive Biotechnologies Announce Strategic Partnership To Develop A Therapeutic To Prevent Or Treat COVID-19

 

Johnson & Johnson and Award-Winning Journalist Lisa Ling Explore What It Takes to End a Pandemic

 

Possible COVID-19 treatment: transfusion of antibodies from recovered patients’ blood

 

Global Plasma Leaders Collaborate to Accelerate Development of Potential COVID-19 Hyperimmune Therapy

 

Area biotech works on treatment for lungs of COVID-19 patients

 

J&J picks top coronavirus vaccine candidate; human tests to start in September

 

Wash U gets FDA clearance to test a century-old idea on critical COVID-19 patients

 

Meet the SLU department on the frontlines of coronavirus vaccine development

Association Management Software Powered by YourMembership  ::  Legal